-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Estrella Immunopharma, Inc. quarterly/annual Current Federal Tax Expense (Benefit) history and growth rate from Q1 2021 to Q2 2023.
- Estrella Immunopharma, Inc. Current Federal Tax Expense (Benefit) for the quarter ending June 30, 2023 was $20.5K.
- Estrella Immunopharma, Inc. Current Federal Tax Expense (Benefit) for the twelve months ending June 30, 2023 was $113K.
- Estrella Immunopharma, Inc. annual Current Federal Tax Expense (Benefit) for 2022 was $51.2K.
Current Federal Tax Expense (Benefit), Trailing 12 Months (USD)
Current Federal Tax Expense (Benefit), Quarterly (USD)